Riggs A
Endocr Rev. 2020; 42(3):374-380.
PMID: 33340315
PMC: 8152450.
DOI: 10.1210/endrev/bnaa029.
Chu Y, Burke G, Ross J, KATSOYANNIS P
J Protein Chem. 1993; 12(4):499-505.
PMID: 8251071
DOI: 10.1007/BF01025051.
Hu S, Burke G, KATSOYANNIS P
J Protein Chem. 1993; 12(6):741-7.
PMID: 8136024
DOI: 10.1007/BF01024932.
Laws W, Schwartz G, Rusinova E, Burke G, Chu Y, KATSOYANNIS P
J Protein Chem. 1995; 14(4):225-32.
PMID: 7662110
DOI: 10.1007/BF01886763.
Schwartz G, Burke G, KATSOYANNIS P
Proc Natl Acad Sci U S A. 1987; 84(18):6408-11.
PMID: 3306677
PMC: 299085.
DOI: 10.1073/pnas.84.18.6408.
Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin.
Ohta N, Burke G, KATSOYANNIS P
J Protein Chem. 1988; 7(1):55-65.
PMID: 3076448
DOI: 10.1007/BF01025414.
A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human).
Schwartz G, Burke G, KATSOYANNIS P
Proc Natl Acad Sci U S A. 1989; 86(2):458-61.
PMID: 2643113
PMC: 286489.
DOI: 10.1073/pnas.86.2.458.
Hybrid molecules containing the B-domain of insulin-like growth factor I are recognized by carrier proteins of the growth factor.
de Vroede M, Rechler M, NISSLEY S, Joshi S, Burke G, KATSOYANNIS P
Proc Natl Acad Sci U S A. 1985; 82(9):3010-4.
PMID: 2581261
PMC: 397696.
DOI: 10.1073/pnas.82.9.3010.
An insulin-like hybrid consisting of a modified A-domain of human insulin-like growth factor I and the B-chain of insulin.
Zong L, Burke G, KATSOYANNIS P
J Protein Chem. 1990; 9(4):389-95.
PMID: 2275749
DOI: 10.1007/BF01024614.
An insulin-like compound consisting of the B-chain of bovine insulin and an A-chain corresponding to a modified A- and the D-domains of human insulin-like growth factor I.
Joshi S, Burke G, KATSOYANNIS P
J Protein Chem. 1990; 9(2):235-46.
PMID: 2201313
DOI: 10.1007/BF01025314.
Insulin analogues with modifications in the beta-turn of the B-chain.
Wang S, Hu S, Burke G, KATSOYANNIS P
J Protein Chem. 1991; 10(3):313-24.
PMID: 1910463
DOI: 10.1007/BF01025630.
The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
Chu Y, Zong L, Burke G, KATSOYANNIS P
J Protein Chem. 1992; 11(5):571-7.
PMID: 1360216
DOI: 10.1007/BF01025035.
2-Sulphobenzyl, a new solubilizing and reversible protecting group for cysteine in proteins. Its scope and limitations.
Ruegg U, Jarvis D, Rudinger J
Biochem J. 1979; 179(1):127-34.
PMID: 475751
PMC: 1186602.
DOI: 10.1042/bj1790127.
4-pyridylmethyl, a thiol-protecting group suitable for the partial synthesis of proteins.
Ruegg U, Jarvis D, Rudinger J
Biochem J. 1979; 179(1):119-26.
PMID: 475750
PMC: 1186601.
DOI: 10.1042/bj1790119.
Synthetic DNA and medicine.
Riggs A, Itakura K
Am J Hum Genet. 1979; 31(5):531-8.
PMID: 389043
PMC: 1685909.
Expression in Escherichia coli of chemically synthesized genes for human insulin.
Goeddel D, Kleid D, Bolivar F, Heyneker H, Yansura D, Crea R
Proc Natl Acad Sci U S A. 1979; 76(1):106-10.
PMID: 85300
PMC: 382885.
DOI: 10.1073/pnas.76.1.106.
